RecruitingNCT06527157

Investigations of Reproductive Cancers in Women

PROspective ACcrual To Investigate reprOductive Cancers in womeN


Sponsor

PinkDx, Inc.

Enrollment

4,500 participants

Start Date

Jul 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.


Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new diagnostic tool to detect endometrial (uterine) cancer or other causes of abnormal uterine bleeding in women who are being worked up for this symptom. The device collects samples non-invasively, and researchers hope it can detect cancer markers early — potentially offering a less invasive alternative to current diagnostic procedures. **You may be eligible if...** - You are a woman aged 45 or older (most participants will be over 50) - You still have a uterus - You are currently being evaluated for abnormal uterine bleeding (AUB) or post-menopausal bleeding (PMB) - You are able to complete study visits and be contacted by phone during the study **You may NOT be eligible if...** - You have had a hysterectomy (uterus removed) - You have a known history of endometrial cancer or uterine sarcoma - You have previously been treated for endometrial cancer - You are suspected to be pregnant - You have used a tampon within 7 days of sample collection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(16)

University of Alabama, Birmingham

Birmingham, Alabama, United States

Sutter Health

Redwood City, California, United States

Advent Health Orlando

Orlando, Florida, United States

Ob-Gyne Associates of Lake Forest, Ltd

Lake Forest, Illinois, United States

Indiana University, Eskenazi Health

Indianapolis, Indiana, United States

Mayo Clinic

Rochester, Minnesota, United States

Washington University School of Medicine

St Louis, Missouri, United States

Columbia University

New York, New York, United States

Summa Health

Akron, Ohio, United States

The Ohio State University

Columbus, Ohio, United States

Avera Research Institute

Sioux Falls, South Dakota, United States

University of Tennessee Health Science Center

Memphis, Tennessee, United States

Meharry Medical College

Nashville, Tennessee, United States

Baylor College of Medicine/Texas Children's Hospital

Houston, Texas, United States

Houston Methodist

Houston, Texas, United States

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06527157


Related Trials